Equine Potomavac™ + IMRAB®
is for vaccinating horses against disease caused by rabies virus and aids in the prevention of disease in horses caused by Potomac horse fever (equine monocytic ehrlichiosis) caused by Ehrlichia risticii. This highly effective combination vaccine contains inactivated E. risticii combined with inactivated rabies virus to help protect your horse against Potomac horse fever which can lead to fever, colic, watery diarrhea and abortion, and rabies, a nervous system infection which is invariably fatal once symptoms develop. Equine Potomavac™ + IMRAB®
is a killed vaccine safe for intramuscular administration in healthy horses and foals at least 3 months of age. Unvaccinated horses will require a primary two-dose vaccination, three to four weeks apart. Annual revaccination is recommended. No reconstitution required.
- Equine combination vaccine
- For use in healthy horses and foals 3 months of age and older
- Protects against rabies virus and Potomac horse fever
- Killed virus vaccine, no mixing required
- Contains inactivated rabies virus
For primary vaccination, aseptically inject 1 mL (1 dose) intramuscularly into healthy horses 3 months of age or older. For E. risticii, revaccinate with 1 dose 3 to 4 weeks later using this product or EQUINE POTOMAVAC™. Revaccinate annually with a single 1 mL dose.
Store at 2-7°C (35-45°F). Do not freeze. Use entire contents when first opened. Shake well before using. Contains gentamicin as a preservative. Do not vaccinate within 21 days prior to slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results.
Questions and Answers
There are no questions or answers for this item.